omniture
logo
Search
正序(上海)生物科技有限公司
Media Room

Latest News

rss

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, ...

2026-06-02 12:50 3917

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, ...

2026-06-02 11:38 4967

The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrati...

2025-11-06 08:00 2219
The World's First Gene-Editing Therapy Targeting APOC3 for Hyperlipidemia

The World's First Clinical Base Editing Therapy for Hemoglobinopathy

CorrectSequence Therapeutics' CS-101 Successfully Cures One Patient of Transfusion-Dependent β-Tha...

2024-01-08 19:46 3740
The World's First Clinical Base Editing Therapy for Hemoglobinopathy